The femoral vein has become an increasingly preferred site for central venous All catheter tip positions were confirmed on plain radiographs immediately after insertion. Tips were positioned to within 5 cm of the right atrium. Catheter lumina used for haemodynamic monitoring were infused with a heparinised (05 units/ml) dextrose or normal saline solution. Unused ('locked') lumina were flushed every six hours with a concentrated heparinised solution (10 units/ml).
ULTRASOUND EXAMINATIONS
All patients underwent ultrasound examination within the first three days after catheter insertion and every two to four days thereafter until removal of the catheter. Wherever possible, patients were studied to within 24 hours of catheter removal. Scans were performed with an Ultramark 4 real time scanner with a 5 or 7 5 mHz transducer and Acuson 1 28XP scanner with colour Doppler if a thrombus was detected.
Results
Over the 14 month study period, 61 femoral venous catheters were inserted in 59 patients who fulfilled the selection criteria. Five patients were not studied due to logistic reasons or refusal to participate in the study. Thus, 56 catheters in 54 patients were available for analysis. There were 32 boys and 22 girls; mean age at the age of insertion was 37-6 months (range 0-5-192 months). There were a wide range of diagnoses, and the overall mortality was 6%. Catheters were in place for a mean (and median) duration of nine days.
IVC thrombosis was identified sonographically in six patients, that is 10-7% (six of 56 of catheters placed). In all six patients, thrombus was detected by ultrasound on or after the eighth day of catheterisation. Five of the six patients had had a negative ultrasound 72 hours previously. Thrombi were detected on days 8, 8, 10, 20, and 20. The sixth patient was entered later in the study and the first ultrasound was not performed until the 13th day after insertion when a thrombus was detected. The time of first appearance of thrombus in this patient is therefore not known. Only one patient with a positive ultrasound had clinical signs of thrombosis. No clinical signs were detected in the remainder of the study population.
The diagnoses of those children with thrombus were: pneumocystis pneumonia in a child on immunosuppressives for renal disease; one patient with a near drowning episode and severe adult respiratory distress syndrome; one patient with staphylococcal pneumonia; one patient with encephalopathy of unknown origin; one patient with haemophilus meningitis; and one patient with a meningoencephalitis of probable viral cause. These clinical pictures did not differ in any significant way from the group without thrombus. The diagnoses in these children included 18 with respiratory pathology including pneumonia; four with meningitis and/or encephalitis; two with near drowning; five with sepsis including two episodes associated with immunosuppression; seven with various central nervous system disorders including trauma and seizures; four children with metabolic or liver disorders; and eight with various miscellaneous diagnoses.
The mean age of those children with and those without thrombus was 37-6 months. Altogether 83% (5/6) of those children with a thrombus had received inotropic medication at some point while the catheter was in situ whereas only 50% (25/50) of those without a thrombus received similar treatment, and the same number of children with thrombosis (5/6) had prolonged coagulation profiles while in the non-thrombosis group only 48% (24/50) had prolonged coagulation profiles. When antithrombin III was measured, two out of five patients (40%) in the thrombosis group and 17 of 45 patients (38%) in the non-thrombosis group had low concentrations.
In each case of IVC thrombosis, the femoral catheter was removed as soon as the diagnosis was made by ultrasound. Five of six cases were followed up with sonograms until complete resolution of the thrombus (five to 31 days). 14 ultrasound has the advantage of being a safe, non-invasive means of studying the IVC, and lends itself well to assessment of critically ill patients immobilised in the intensive care unit. The ability of ultrasound to visualise clearly the IVC and identify the presence of intraluminal thrombus has been well documented. 10 15 16 Furthermore, in the evaluation of thrombi in the IVC, ultrasound may have an additional advantage over venography in more clearly delineating the cephalad extent of thrombotic occlusion. 15 Previous data have suggested a relationship between the length of time a catheter is in situ and thrombotic complications.9 12 14 17 In our study, no thrombi were identified on ultrasound before eight days of catheter use and it seems reasonable to assume that patients with femoral catheters in for fewer than seven days are at lower risk.
The low incidence of IVC thrombosis in our study precludes clear definition of specific at risk patients. However, the majority of our cases with positive ultrasound findings received inotropes. This supports previous observations that dehydration and low perfusion may predispose to thrombus formation in association with intravascular catheters. Decreased antithrombin III concentrations in the majority of patients in this setting suggest that this test is unlikely to be useful as a predictor of increased risk.
The risk of pulmonary embolus in the presence of IVC thrombosis in adults has been well described. '8 19 No patients in our study exhibited obvious signs of pulmonary embolus but many were intubated and artificially ventilated for severe pulmonary disease. The risk of this potentially lethal complication associated with catheter related thrombus in the IVC is unknown, although pulmonary embolism has been reported in association with femoral catheterisation.9 20 Guidelines for the management of IVC thrombosis in the paediatric patient in this setting are lacking. Anticoagulation was instituted in one patient with extensive thrombosis reflected by the appearance of clinical signs and the slow resolution of the thrombus. It is difficult to make firm recommendations but appropriate management would appear to consist of removal of the catheter, institution of anticoagulation, and regular follow up ultrasonography.
In summary, we were able to detect the presence ofthrombus in the IVC of 10% of critically ill patients catheterised via the femoral route using serial bedside ultrasound examinations. While it is possible that a subgroup of patients with more severe illness may be at higher risk of developing this complication, we were unable to define adequately the risk factors. We found a relationship between thrombus formation and duration of catheter use and recommend routine ultrasound study of all patients with femoral central venous catheters in situ for six or more days. Scans should be performed twice a week. thereafter for the duration of catheter use. An alternative strategy would be to change routinely the site of the central venous catheter at six days. Although the embolic risk is unknown, we advise removal of the catheter if a thrombus is identified, anticoagulation, and twice weekly ultrasound follow up until complete recanalisation.
complication of femoral vein catheterisation. 
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